Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/15/2023 | Garrett Motion Inc. | GTX | Sale | Common Stock | 1M | $7.55 | $7.7M | See Footnotes | 06/13/2023 |
06/14/2023 | Garrett Motion Inc. | GTX | Sale | Common Stock | 3.1M | $7.73 | $24M | See Footnotes | 06/13/2023 |
06/13/2023 | Garrett Motion Inc. | GTX | Conversion | Series A Cumulative Convertible Preferred Stock | 25.5M | $0.00 | $0 | See Footnotes | 06/13/2023 |
06/13/2023 | Garrett Motion Inc. | GTX | Conversion | Common Stock | 25.5M | $0.00 | $0 | See Footnotes | 06/13/2023 |
06/13/2023 | Garrett Motion Inc. | GTX | Sale | Common Stock | 500k | $8.00 | $4M | See Footnotes | 06/13/2023 |
06/08/2023 | Garrett Motion Inc. | GTX | Sale | Common Stock | 500k | $8.20 | $4.1M | See Footnotes | 06/08/2023 |
06/08/2023 | Garrett Motion Inc. | GTX | Sale | Series A Preferred Stock | 17.5k | $0.00 | $0 | See Footnotes | 06/08/2023 |
12/10/2021 | Garrett Motion Inc. | GTX | Sale | Series A Preferred Stock | 1.8M | $8.20 | $15M | See Footnotes | 12/10/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Other (disposition) | Common Stock | 18M | $38.00 | $685.7M | See footnote 1 and 2 | 09/14/2021 |
05/11/2021 | Garrett Motion Inc. | GTX | Sale | Series A Preferred Stock | 761.9k | $0.00 | $0 | See Footnotes | 05/11/2021 |
05/07/2021 | Garrett Motion Inc. | GTX | Sale | Series A Preferred Stock | 381k | $0.00 | $0 | See Footnotes | 05/07/2021 |
04/30/2021 | Garrett Motion Inc. | GTX | Other (disposition) | Common Stock | 3.6M | $0.00 | $0 | See Footnotes | 04/30/2021 |
07/23/2020 | VIASAT INC | VSAT | Purchase | Common Stock | 2.6M | $39.11 | $100M | See footnote 1. | 07/23/2020 |
06/26/2020 | Translate Bio, Inc. | TBIO | Purchase | Common Stock | 500k | $22.00 | $11M | See footnote 1 and 2. | 06/26/2020 |
05/31/2019 | Orexigen Therapeutics, Inc. | OREXQ | Other (disposition) | 0% Senior Secured Convertible Notes due 2020 | 0 | $0.00 | $0 | See footnote | 05/31/2019 |
05/31/2019 | Orexigen Therapeutics, Inc. | OREXQ | Other (disposition) | Warrant Expiring 2020 | 5M | $0.00 | $0 | See footnote | 05/31/2019 |
05/31/2019 | Orexigen Therapeutics, Inc. | OREXQ | Other (disposition) | Warrant Expiring 2026 | 100M | $0.00 | $0 | See footnote | 05/31/2019 |
12/12/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Disposition | Common Stock | 65.4M | $0.00 | $0 | See footnote 1 and 2 | 12/11/2018 |
12/11/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Exercise | Zero Coupon Senior Convertible Notes due 2021 | 0 | $4.63 | $0 | See footnote 1 and 2 | 12/11/2018 |
12/11/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Grant | Common Stock | 35.6M | $4.63 | $164.7M | See footnote 1 and 2 | 12/11/2018 |
12/11/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Grant | Common Stock | 4M | $0.00 | $0 | See footnote 1 and 2 | 12/11/2018 |
10/31/2018 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 896.3k | $0.01 | $9k | See footnote 1 and 2 | 10/29/2018 |
10/29/2018 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 650k | $0.01 | $6.5k | See footnote 1 and 2 | 10/29/2018 |
10/25/2018 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 652.5k | $0.01 | $6.5k | See footnote 1 and 2 | 10/24/2018 |
10/24/2018 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 28k | $0.01 | $280 | See footnote 1 and 2 | 10/24/2018 |
05/08/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Disposition | Zero Coupon Convertible Senior Notes due 2020 | 0 | $3.74 | $0 | See footnote 1. | 05/08/2018 |
05/08/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Grant | Zero Coupon Senior Convertible Notes due 2021 | 0 | $4.63 | $0 | See footnote 1 and 2. | 05/08/2018 |
04/13/2018 | Orexigen Therapeutics, Inc. | OREXQ | Other (disposition) | 0% Senior Secured Convertible Notes due 2020 | 16.5M | $7.50 | $123.6M | See footnote 1 and 2 | 04/13/2018 |
08/05/2014 | IDENIX PHARMACEUTICALS INC | IDIX | Other (disposition) | Common Stock | 53.3M | $24.50 | $1306.6M | See Footnote | 08/05/2014 |
01/31/2014 | IDENIX PHARMACEUTICALS INC | IDIX | Purchase | Common Stock | 16.4M | $6.50 | $106.7M | See footnote. | 01/31/2014 |
04/19/2010 | ABBOTT BIOTHERAPEUTICS CORP | FACT | Other | Common Stock, $0.01 par value per share | 1.5M | $27.00 | $40.5M | See Footnote | 04/19/2010 |
04/08/2010 | ABBOTT BIOTHERAPEUTICS CORP | FACT | Sale | Common Stock, $0.01 par value per share | 500k | $26.96 | $13.5M | See Footnote | 04/08/2010 |
03/16/2010 | ABBOTT BIOTHERAPEUTICS CORP | FACT | Sale | Common Stock, $0.01 par value per share | 1.5M | $27.00 | $40.7M | See Footnote | 03/16/2010 |
12/24/2009 | RHI Entertainment, Inc. | RHIE | Sale | Common Stock, $0.01 par value per share | 1.9M | $0.42 | $776.2k | I | 12/24/2009 |
12/24/2009 | RHI Entertainment, Inc. | RHIE | Sale | Common Stock, $0.01 par value per share | 713.7k | $0.43 | $305.5k | I | 12/24/2009 |
|